Global Genome (DNA) Sequencing Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Genome (DNA) Sequencing Market Insights, Forecast to 2034
Genome (DNA) sequencing is a method that allows several DNA strands to be sequenced simultaneously. Genome sequencing technology aids in the sequencing of an organism's whole genome in order to determine the order or sequence of DNA nucleotides or bases coded with letters including As, Gs, Cs, and Ts. Genome sequencing methods made it feasible to investigate genetics, biomarkers, forensics, customized medicine, and other fields. This technology aids in the transition from traditional procedures to customized medications with the use of genetics. It is a widely utilized method for whole-genome sequencing.
Market Analysis and InsightsGlobal Genome (DNA) Sequencing Market
Global Genome (DNA) Sequencing market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Genome (DNA) Sequencing industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
Globally, Genome (DNA) Sequencing key companies include Agilent Technologies Inc., BGI, Bio-Rad Laboratories, Danaher, F. Hoffmann-La Roche Ltd., Genome Electric Company, Illumina Inc., IntegraGen and Oxford Nanopore Technologies, etc. Agilent Technologies Inc., BGI, Bio-Rad Laboratories are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Genome (DNA) Sequencing were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Genome (DNA) Sequencing market and estimated to attract more attentions from industry insiders and investors.
Genome (DNA) Sequencing can be divided into Next-Generation Sequencing, Third Generation DNA Sequencing and Others,, etc. Next-Generation Sequencing is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Genome (DNA) Sequencing is widely used in various fields, such as Research Institutes, Pharmaceutical & Biotechnological Companies and Healthcare Facilities & Diagnostic Centres,, etc. Research Institutes provides greatest supports to the Genome (DNA) Sequencing industry development. In 2022, global % revenue of Genome (DNA) Sequencing went into Research Institutes filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Genome (DNA) Sequencing market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Genome (DNA) Sequencing market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
Agilent Technologies Inc.
BGI
Bio-Rad Laboratories
Danaher
F. Hoffmann-La Roche Ltd.
Genome Electric Company
Illumina Inc.
IntegraGen
Oxford Nanopore Technologies
Pacific Biosciences of California Inc.
QIAGEN
Thermo Fisher Scientific Inc.
Segment by Type
Next-Generation Sequencing
Third Generation DNA Sequencing
Others
Research Institutes
Pharmaceutical & Biotechnological Companies
Healthcare Facilities & Diagnostic Centres
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Genome (DNA) Sequencing introduction, etc. Genome (DNA) Sequencing Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Genome (DNA) Sequencing
Chapter 13Methodology and Data Sources adopted by MRAResearch
Market Analysis and InsightsGlobal Genome (DNA) Sequencing Market
Global Genome (DNA) Sequencing market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Genome (DNA) Sequencing industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
Globally, Genome (DNA) Sequencing key companies include Agilent Technologies Inc., BGI, Bio-Rad Laboratories, Danaher, F. Hoffmann-La Roche Ltd., Genome Electric Company, Illumina Inc., IntegraGen and Oxford Nanopore Technologies, etc. Agilent Technologies Inc., BGI, Bio-Rad Laboratories are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Genome (DNA) Sequencing were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Genome (DNA) Sequencing market and estimated to attract more attentions from industry insiders and investors.
Genome (DNA) Sequencing can be divided into Next-Generation Sequencing, Third Generation DNA Sequencing and Others,, etc. Next-Generation Sequencing is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Genome (DNA) Sequencing is widely used in various fields, such as Research Institutes, Pharmaceutical & Biotechnological Companies and Healthcare Facilities & Diagnostic Centres,, etc. Research Institutes provides greatest supports to the Genome (DNA) Sequencing industry development. In 2022, global % revenue of Genome (DNA) Sequencing went into Research Institutes filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Genome (DNA) Sequencing market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Genome (DNA) Sequencing market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
By Company
Agilent Technologies Inc.
BGI
Bio-Rad Laboratories
Danaher
F. Hoffmann-La Roche Ltd.
Genome Electric Company
Illumina Inc.
IntegraGen
Oxford Nanopore Technologies
Pacific Biosciences of California Inc.
QIAGEN
Thermo Fisher Scientific Inc.
Segment by Type
Next-Generation Sequencing
Third Generation DNA Sequencing
Others
Segment by Application
Research Institutes
Pharmaceutical & Biotechnological Companies
Healthcare Facilities & Diagnostic Centres
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Genome (DNA) Sequencing introduction, etc. Genome (DNA) Sequencing Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Genome (DNA) Sequencing
Chapter 13Methodology and Data Sources adopted by MRAResearch